Lifeward (LFWD) Net Income (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -101.81% |
| Dec 31, 2025 | -68.71% |
| Sep 30, 2025 | 51.69% |
| Jun 30, 2025 | -35.75% |
| Mar 31, 2025 | 68.36% |
| Dec 31, 2024 | -395.40% |
| Sep 30, 2024 | 28.35% |
| Jun 30, 2024 | 31.42% |
| Mar 31, 2024 | -11.30% |
| Dec 31, 2023 | 25.12% |
| Sep 30, 2023 | -62.24% |
| Jun 30, 2023 | -7.43% |
| Mar 31, 2023 | 18.67% |
| Dec 31, 2022 | 2.69% |
| Sep 30, 2022 | -22.81% |
| Jun 30, 2022 | -2.21% |
| Mar 31, 2022 | -12.75% |
| Dec 31, 2021 | -44.22% |
| Sep 30, 2021 | 14.84% |
| Jun 30, 2021 | -2.58% |
| Mar 31, 2021 | -3.97% |
| Dec 31, 2020 | 11.72% |
| Sep 30, 2020 | -16.85% |
| Jun 30, 2020 | 25.65% |
| Mar 31, 2020 | -7.41% |
| Dec 31, 2019 | -5.49% |
| Sep 30, 2019 | 26.12% |
| Jun 30, 2019 | -14.67% |
| Mar 31, 2019 | 20.29% |
| Dec 31, 2018 | -10.70% |
| Sep 30, 2018 | 21.80% |
| Jun 30, 2018 | 8.38% |
| Mar 31, 2018 | -2.68% |
| Dec 31, 2017 | -5.41% |
| Sep 30, 2017 | 7.34% |
| Jun 30, 2017 | 1.42% |
| Mar 31, 2017 | 25.09% |
| Dec 31, 2016 | -7.88% |
| Sep 30, 2016 | 13.13% |
| Jun 30, 2016 | -31.71% |
| Mar 31, 2016 | 7.79% |
| Dec 31, 2015 | -17.41% |
| Sep 30, 2015 | -10.09% |
| Jun 30, 2015 | -1.79% |
| Mar 31, 2015 | -4.07% |
| Dec 31, 2014 | 14.74% |
| Dec 31, 2013 | -5.29% |